Today is World Obesity Day – a moment to pause and reflect on one of the fastest-growing global health challenges of our time. More than 1 billion people worldwide are currently living with obesity. By 2035, that number is expected to rise significantly, with nearly half of the global population … Read more
Double Board-Certified Obesity, Diabetes & Integrative Medicine Specialist to Lead Medical Strategy, Sponsor Engagement, and Industry Collaboration AUSTIN, TX – GLOBE NEWSWIRE – Tekton Research, a leading multi-site clinical trial organization with 25 research sites across North America, today announced the appointment of Jara McDonald, MD, FAAFP, DABOM, as Executive … Read more
Site networks are undergoing a meaningful shift. What were once loosely connected groups of investigators are evolving into more structured, operationally unified organizations designed to deliver greater consistency, scalability, and performance for sponsors. In a recent feature by Dan Schell in Clinical Leader, Tekton Research CEO Corey Collins shares perspective … Read more
February is Black History Month, a time to celebrate the achievements, resilience, and lasting impact of Black leaders across every field, including medicine and clinical research. At Tekton Research, we take this opportunity to reflect on the pioneers whose contributions have shaped the medical world and the lessons their stories … Read more
Tekton Research is pleased to welcome Dr. Arti Thangudu as a Principal Investigator in San Antonio, Texas, further strengthening our growing network of physician-led clinical research sites. Dr. Thangudu is a triple board-certified physician in Endocrinology, Diabetes & Metabolism, and Internal Medicine, bringing more than a decade of clinical experience … Read more
As the pace of clinical research continues to accelerate, 2025 marked a year of focused, intentional growth for Tekton Research — particularly in high-demand therapeutic areas like neuroscience and cardiometabolic health. Rather than expanding for expansion’s sake, our work this year centered on strengthening the capabilities that matter most to … Read more
Growth strengthens Tekton’s regional density and enhances access to diverse patient populations AUSTIN, TX – Tekton Research, a leading multi-site clinical trial organization, today announced the addition of two new research sites in New Carlisle, Ohio, and Englewood, New Jersey. The expansion supports Tekton’s continued growth in Neuroscience and General … Read more
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 – Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, … Read more
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 – Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These … Read more
From continuous glucose monitors to heart rate sensors, the tools patients use to monitor their health have never been more advanced-or more essential. At Tekton, we’re proud to conduct clinical trials for diagnostic devices and health technology that help shape the future of care. Whether it’s validating a new temperature … Read more
Subscribe to Inside Tekton on LinkedIn
Get Tekton's monthly newsletter that rounds up the latest from Tekton, and the clinical research landscape.